Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today…
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol Myers Squibb”) announced today the commencement of its offers to exchange (the “Registered…
DUBLIN–(BUSINESS WIRE)–The “COVID-19 Therapeutics Experiments News – Bundle” newsletter has been added to ResearchAndMarkets.com’s offering. The COVID-19 Therapeutics Experiments News…
DUBLIN–(BUSINESS WIRE)–The “Nucleic Acid Isolation and Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA,…
Sanofi on Tuesday detailed plans investing in France to increase its vaccines research and production capacities, and contribute in responding to future pandemic risks, aligned with its corporate strategy presented last December, Sanofi will invest €610 million to create a new production site and research center in France with both dedicated to vaccines.
Significant revenue growth of 114% compared to 2018, EBITDA slightly positive Product business further expanded and organizational growth driven forward…
Tilt Biotherapeutics has secured an additional EUR 6.2m, including EUR 4.5m equity, to advance its proprietary, best-in-class cytokine armed oncolytic adenovirus, TILT-123, into Phase 1 clinical trials
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form…
To Commence Trading on Nasdaq Capital Market on June 16, 2020 Under Ticker Symbol “FBRX” TORRANCE, Calif.–(BUSINESS WIRE)–Forte Biosciences, Inc.…
BOSTON–(BUSINESS WIRE)–AVEO Oncology (Nasdaq: AVEO) today announced that it has commenced an underwritten public offering of $40.0 million of shares…